A5080168252- Diabetes, Cardiovascular Risks, and Lipoproteins
- Lipoproteins and Cardiovascular Health
- Health Systems, Economic Evaluations, Quality of Life
- Diabetes Treatment and Management
- Pharmacology and Obesity Treatment
- Cardiac Health and Mental Health
- Cardiovascular Function and Risk Factors
- Diabetes Management and Research
- Heart Failure Treatment and Management
- Rheumatoid Arthritis Research and Therapies
- Acute Myocardial Infarction Research
- Blood Pressure and Hypertension Studies
- Spondyloarthritis Studies and Treatments
- Heart Rate Variability and Autonomic Control
- Psoriasis: Treatment and Pathogenesis
- Cardiac Imaging and Diagnostics
- Telemedicine and Telehealth Implementation
- Cardiac pacing and defibrillation studies
- Health and Lifestyle Studies
- Autoimmune Bullous Skin Diseases
- Dermatological and COVID-19 studies
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Effects of Exercise
- Healthcare Systems and Technology
- Chronic Disease Management Strategies
Spanish Society of Family and Community Medicine
2020-2024
Fundación Centro Tecnológico de la Información y la Comunicación
2024
Sociedad Española de Medicina Interna
2023
Consejería de Salud y Consumo
2019-2020
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2018
Hospital General Universitario Gregorio Marañón
2015
Universidad Autónoma de Madrid
2010-2015
Barro Colorado Island
2015
Madrid Health Service
2013
Hospital de León
2000
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are indicated in type 2 diabetes and obesity for their high efficacy controlling glycaemia inducing body weight loss, respectively. Patients may develop gastrointestinal adverse events (GI AEs), namely nausea, vomiting, diarrhoea and/or constipation. To minimize severity duration, healthcare providers (HCPs) patients must be aware of appropriate measures to follow while undergoing treatment. An expert panel comprising endocrinologists,...
Diabetes mellitus (DM) is a highly prevalent disease worldwide, estimated to affect 1 in every 11 adults; among them, 90–95% of cases are type 2 diabetes mellitus. This partly attributed the surge prevalence obesity, which has reached epidemic proportions since 2008. In these patients, cardiovascular (CV) risk stands as primary cause morbidity and mortality, placing substantial burden on healthcare systems due potential for macrovascular microvascular complications. this context, leptin, an...
The successful implementation of cardiovascular disease (CVD) prevention guidelines relies heavily on primary care physicians (PCPs) providing risk factor evaluation, intervention and patient education. aim this study was to ascertain the degree awareness Spanish adaptation European CVD in clinical practice (CEIPC guidelines) among PCPs. A cross-sectional survey PCPs conducted Spain between January June 2011. random sample 1,390 obtained stratified by region. Data were collected means a...
The present paper updates the Clinical Practice Recommendations for management of cardiovascular risk factors (CVRF) in diabetes mellitus. This is a medical consensus agreed by an independent panel experts from Spanish Society Diabetes (SED). Several consensuses have been proposed scientific and Societies to achieve clinical goals. However, score general population may lack sensitivity individual assessment or particular groups at risk, such as diabetics. Traditional together with...
Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control lipid metabolism disorders is a key challenge cardiovascular prevention that far from being achieved real clinical practice. There great heterogeneity reports Spanish laboratories, which may contribute its poor control. For this reason, working group scientific societies involved care patients at vascular risk, has prepared document with consensus proposal on determination basic profile...
Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control lipid metabolism disorders is a key challenge cardiovascular prevention that far from being achieved real clinical practice. There great heterogeneity reports Spanish laboratories, which may contribute its poor control. For this reason, working group scientific societies involved care patients at vascular risk, has prepared document with consensus proposal on determination basic profile...
Slipping rib syndrome is an overlooked cause of persistent abdominal or chest pain. The etiology this not well understood, but the characteristic pain from hypermobility false ribs. Although it a diagnosis exclusion, misdiagnosis may lead to excessive workup. A simple clinical examination via hooking maneuver most significant feature its diagnosis. We describe case 41-year-old woman with slipping syndrome.
Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control lipid metabolism disorders is a key challenge cardiovascular prevention that far from being achieved real clinical practice. There great heterogeneity reports Spanish laboratories, which may contribute its poor control. For this reason, working group scientific societies involved care patients at vascular risk, has prepared document with consensus proposal on determination basic profile...
Abstract Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control lipid metabolism disorders is a key challenge cardiovascular prevention that far from being achieved real clinical practice. There great heterogeneity reports Spanish laboratories, which may contribute its poor control. For this reason, working group scientific societies involved care patients at vascular risk, has prepared document with consensus proposal on determination basic...
Abstract Healthy lifestyle interventions and drug therapies are proven to have a positive preventative influence on normal glucose regulation in prediabetes. However, little is known the specific role that these factors play reversion glycemia according type of We used data from Observational prospective cohort study, The Cohort study Primary Health Care Evolution Patients with Prediabetes 2012 2015. A total 1184 individuals aged 30–74 years old were included classified based ADA three...